Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Pharma Company Licenses Protein Delivery Hydrogel

Gel sample

A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel

University Lab Licenses Printed Kidney Tissue Process

Kidney organoid with capillary

A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process

Trial Shows Immunotherapy Improves Lung Cancer Survival

Inspecting lung X-rays

Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival

Biotech Partners on Gene Editing Tech in $1.35B Deal

Gene therapy graphic

A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal

Bio-Based Material Shown to Aid Tendon Repair

Dusky Marion sea slug

Academic and industry researchers demonstrated in lab animals a tough material derived from natural sources that speeds repair of injured tendons. . . . → Read More: Bio-Based Material Shown to Aid Tendon Repair

India Authorizes Covid-19 Vaccines Designed in US

The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs. . . . → Read More: India Authorizes Covid-19 Vaccines Designed in US

Small Biz Grant Funds Biofilm Infection Peptides

Pseudomonas aeruginosa

A start-up company is receiving a National Institutes of Health grant to develop peptides for preventing bacterial films causing middle ear infections. . . . → Read More: Small Biz Grant Funds Biofilm Infection Peptides

Regeneron Gains Cancer, Infectious Disease Immunotherapies

Regeneron lab

A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies

New Company to Develop Synthetic Antibody Therapies

SARS-CoV-2 particle

A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins. . . . → Read More: New Company to Develop Synthetic Antibody Therapies

Joint Venture to Develop Stable RNA Covid-19 Vaccine

Shark

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine